Neogenomics (NEO) PT Lowered to $60 at Benchmark

March 25, 2021 7:07 AM EDT Send to a Friend

Benchmark analyst Bruce Jackson lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Neogenomics (NEO) PT Lowered to $60 at Benchmark

Member Login

Free News Feed